List of works - Delia J. Nelson

A review of the importance of immune responses in luminal B breast cancer.

scientific article published on 19 January 2017

Aged neutrophils accumulate in lymphoid tissues from healthy elderly mice and infiltrate T and B cell zones

scientific article published on 30 March 2018

Aging and cancer: The role of macrophages and neutrophils.

scientific article published on 5 April 2017

Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?

scientific article

Basic science funding in Australia: lessons from the EU

scientific article published on 01 October 2002

Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment.

scientific article

CD40-activated B cells contribute to mesothelioma tumor regression.

scientific article published on 13 July 2010

Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo.

scientific article

Cross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulation.

scientific article

Deliberately provoking local inflammation drives tumors to become their own protective vaccine site.

scientific article published on 29 September 2008

Dendritic cells infected with a vaccinia virus interleukin-2 vector secrete high levels of IL-2 and can become efficient antigen presenting cells that secrete high levels of the immunostimulatory cytokine IL-12.

scientific article published in August 2003

Development of the airway intraepithelial dendritic cell network in the rat from class II major histocompatibility (Ia)-negative precursors: differential regulation of Ia expression at different levels of the respiratory tract.

scientific article published on January 1994

Effect of ozone exposure on alveolar macrophage-mediated immunosuppressive activity in rats

scientific article published on 01 February 1998

Functional endogenous cytotoxic T lymphocytes are generated to multiple antigens co-expressed by progressing tumors; after intra-tumoral IL-2 therapy these effector cells eradicate established tumors

scientific article published on 11 November 2005

Human mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomes

scientific article published on 31 August 2015

IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice.

scientific article published on 19 April 2014

Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses ⬇️

scientific article published on October 15, 2011

Lipid-laden partially-activated plasmacytoid and CD4(-)CD8α(+) dendritic cells accumulate in tissues in elderly mice

scientific article

Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells.

scientific article

Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function

scientific article

Modulation of dendritic cell and T cell cross-talk during aging: The potential role of checkpoint inhibitory molecules.

scientific article

Murine mesothelioma induces locally-proliferating IL-10(+)TNF-α(+)CD206(-)CX3CR1(+) M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy

scientific article published on 22 April 2016

Rapid copper acquisition by developing murine mesothelioma: decreasing bioavailable copper slows tumor growth, normalizes vessels and promotes T cell infiltration

scientific article

Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces

scientific article

Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice.

scientific article published on 27 March 2013

The "Trojan Horse" approach to tumor immunotherapy: targeting the tumor microenvironment

scientific article

The Use of Agonistic Anti-CD40 Therapy in Treatments for Cancer ⬇️

scientific article published on August 1, 2012

Tumor growth or regression: powered by inflammation.

scientific article published on 24 July 2006

Turning the tumor microenvironment into a self vaccine site.

scientific article published on September 2012

List of works by Delia J. Nelson

A review of the importance of immune responses in luminal B breast cancer.

Aged neutrophils accumulate in lymphoid tissues from healthy elderly mice and infiltrate T and B cell zones

Aging and cancer: The role of macrophages and neutrophils.

Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?

Basic science funding in Australia: lessons from the EU

Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment.

CD40-activated B cells contribute to mesothelioma tumor regression.

Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo.

Cross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulation.

Deliberately provoking local inflammation drives tumors to become their own protective vaccine site.

Dendritic cells infected with a vaccinia virus interleukin-2 vector secrete high levels of IL-2 and can become efficient antigen presenting cells that secrete high levels of the immunostimulatory cytokine IL-12.

Development of the airway intraepithelial dendritic cell network in the rat from class II major histocompatibility (Ia)-negative precursors: differential regulation of Ia expression at different levels of the respiratory tract.

Effect of ozone exposure on alveolar macrophage-mediated immunosuppressive activity in rats

Functional endogenous cytotoxic T lymphocytes are generated to multiple antigens co-expressed by progressing tumors; after intra-tumoral IL-2 therapy these effector cells eradicate established tumors

Human mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomes

IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice.

Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses ⬇️

Lipid-laden partially-activated plasmacytoid and CD4(-)CD8α(+) dendritic cells accumulate in tissues in elderly mice

Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells.

Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function

Modulation of dendritic cell and T cell cross-talk during aging: The potential role of checkpoint inhibitory molecules.

Murine mesothelioma induces locally-proliferating IL-10(+)TNF-α(+)CD206(-)CX3CR1(+) M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy

Rapid copper acquisition by developing murine mesothelioma: decreasing bioavailable copper slows tumor growth, normalizes vessels and promotes T cell infiltration

Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces

Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice.

The "Trojan Horse" approach to tumor immunotherapy: targeting the tumor microenvironment

The Use of Agonistic Anti-CD40 Therapy in Treatments for Cancer ⬇️

Tumor growth or regression: powered by inflammation.

Turning the tumor microenvironment into a self vaccine site.